Intracellular Free Magnesium Deficiency Plays a Key Role in Increased Platelet Reactivity in Type II Diabetes Mellitus

Objective Mg deficiency may be an important factor leading to cardiovascular disease. Diabetic subjects show an increase in platelet reactivity that can enhance the risks of vascular disease. In addition, diabetic patients have been reported to be at risk of developing extracellular Mg deficiency. However, the intracellular free Mg concentration and its role in the enhanced platelet reactivity in diabetes is not known. Research Design and Methods We evaluated the intracellular erythrocyte (RBC) Mg2+ concentration in 20 non-insulin-dependent (type II) diabetics. In addition, the effects of intravenous 3-h drip or 8 wk of oral Mg supplementation on intracellular RBC Mg2+ levels and platelet reactivity was studied. To more clearly evaluate the direct role of Mg in these effects, we induced isolated Mg deficiency in 16 nondiabetic control subjects with an Mg-free liquid diet for 3 wk. Results The intracellular RBC Mg2+ concentration of diabetic patients was significantly reduced compared with values in nondiabetic control subjects (166 ± 7 vs. 204 ± 7 μM, P < 0.01). Serum Mg levels were also reduced in the diabetic patients compared with the control subjects (1.59 ± 0.04 vs. 1.9 ± 0.1 mEq/L, P < 0.05). Oral Mg supplementation for 8 wk (400 mg/day) restored RBC Mg2+ concentration to normal without significantly changing serum Mg concentration. Both intravenous and oral Mg supplementation markedly reduced platelet reactivity in response to the thromboxane A2 analog, U46619. The Mg-free diet resulted in a significant reduction in RBC Mg2+ concentration and markedly enhanced the sensitivity of platelet aggregation to U46619 and ADP. Conclusions These results suggest that type II diabetic patients have intracellular Mg2+ deficiency and that Mg deficiency may be a key factor in leading to enhanced platelet reactivity in type II diabetes. Therefore, Mg supplementation may provide a new therapeutic approach to reducing vascular disease in patients with diabetes.

[1]  H. C. Hartzell,et al.  Effects of intracellular free magnesium on calcium current in isolated cardiac myocytes. , 1988, Science.

[2]  R. Barbour,et al.  Magnesium dietary intake modulates blood lipid levels and atherogenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Rude,et al.  Low blood mononuclear cell magnesium content and hypocalcemia in normomagnesemic patients. , 1987, The Western journal of medicine.

[4]  S. Broste,et al.  Myocardial magnesium: relation to laboratory and clinical variables in patients undergoing cardiac surgery. , 1991, Journal of the American College of Cardiology.

[5]  J. Mustard,et al.  Effect of external calcium and magnesium on thrombin-induced changes in calcium and magnesium of pig platelets. , 1973, The American journal of physiology.

[6]  P. Halushka,et al.  Do Platelets Have Anything To Do With Diabetic Microvascular Disease? , 1983, Diabetes.

[7]  L. Travis,et al.  Hyperphosphaturia and Hypermagnesuria in Children With IDDM , 1990, Diabetes Care.

[8]  J. Nadler,et al.  Evidence that prostacyclin mediates the vascular action of magnesium in humans. , 1987, Hypertension.

[9]  B. Altura,et al.  New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects. , 1985, Magnesium.

[10]  K Kobayashi,et al.  [Diabetes mellitus and hypertension]. , 1968, Naika. Internal medicine.

[11]  S. Fujii,et al.  Magnesium levels of plasma, erythrocyte and urine in patients with diabetes mellitus. , 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[12]  J. Mitchell,et al.  The Effect of Agents which Modify Platelet Behaviour and of Magnesium Ions on Thrombus Formation In Vivo , 1979, Thrombosis and Haemostasis.

[13]  M.P.H. F.A.C.N. Mildred S. Seelig M.D..  Magnesium Deficiency in the Pathogenesis of Disease , 1980, Topics in Bone and Mineral Disorders.

[14]  M. C. Bell,et al.  Effects of hypomagnesemia on reactivity of bovine and ovine platelets: possible relevance to infantile apnea and sudden infant death syndrome. , 1990, Journal of the American College of Nutrition.

[15]  H. Foster.  DIABETES MELLITUS AND LOW ENVIRONMENTAL MAGNESIUM LEVELS , 1987, The Lancet.

[16]  J. Benovic,et al.  The determination of the free magnesium level in the human red blood cell by 31P NMR. , 1978, The Journal of biological chemistry.

[17]  I. Gunn,et al.  Plasma ultrafiltrable magnesium in insulin dependent diabetics. , 1987, Journal of clinical pathology.

[18]  R. Kitzes,et al.  Magnesium sulfate and digitalis-toxic arrhythmias. , 1983, JAMA.

[19]  J. Fuller.  Epidemiology of Hypertension Associated with Diabetes Mellitus , 1985, Hypertension.

[20]  S. D. Collins,et al.  Differential compartmentation of magnesium and calcium in murine S49 lymphoma cells. , 1984, The Journal of biological chemistry.

[21]  K. E. Holley,et al.  Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study. , 1988, Mayo Clinic proceedings.

[22]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[23]  J. Laragh,et al.  Intracellular free magnesium in hypertension: relation to peripheral insulin resistance , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[24]  C. Florén,et al.  Magnesium Deficiency in IDDM Related to Level of Glycosylated Hemoglobin , 1986, Diabetes.

[25]  N. Ward,et al.  Fasting plasma magnesium concentrations and glucose disposal in diabetes. , 1984, British medical journal.

[26]  L. Neri,et al.  WATER HARDNESS AND CARDIOVASCULAR MORTALITY , 1978, Annals of the New York Academy of Sciences.

[27]  J. Nadler,et al.  Mechanisms of blood pressure regulation by magnesium in man. , 1989, Magnesium.

[28]  G. Davı̀,et al.  Thromboxane biosynthesis and platelet function in type II diabetes mellitus. , 1990, The New England journal of medicine.

[29]  J. Laragh,et al.  Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Corkey,et al.  Regulation of free and bound magnesium in rat hepatocytes and isolated mitochondria. , 1986, The Journal of biological chemistry.

[31]  R. A. Reinhart.  Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system. , 1991, American heart journal.

[32]  R. Wallace,et al.  Relationship between diabetes mellitus mortality rates and drinking water magnesium levels in Iowa. , 1990, Magnesium and trace elements.

[33]  M. Ryan,et al.  Magnesium depletion as a cause of refractory potassium repletion. , 1985, Archives of internal medicine.

[34]  R. A. Reinhart.  Magnesium metabolism. A review with special reference to the relationship between intracellular content and serum levels. , 1988, Archives of internal medicine.

[35]  B. Roth.  Modulation of phosphatidylinositol-4,5-bisphosphate hydrolysis in rat aorta by guanine nucleotides, calcium and magnesium. , 1987, Life sciences.